Instances of delayed gastric emptying can occur even after patients have been taking GLP-1 RAs for more than three years
Beyond glycemic control, GLP-1 medications slow gastric emptying, which prolongs the sensation of fullness after eating and contributes to reduced appetite
The eligibility criteria for Semaglutide GLP-1 treatment may vary depending on the healthcare provider and the specific guidelines they follow
Its a series of stages, each with its own biology
With so little direct research, clinical guidelines often lean on what we can reasonably assume from the medication design and its composition, like its size, how the body absorbs it, and how likely it is to pass into breast milk, instead of real-world studies in breastfeeding mothers and babies
GLP-1: Molecular mechanisms and outcomes of a complex signaling system